Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Humacyte (HUMA.US)$ Humacyte Reports Positive Results From ATEV Treatment of Vascular Trauma in Ukraine
MT Newswires· 5 mins ago
Humacyte (HUMA) on Tuesday reported positive long-term results from its humanitarian program in Ukraine using the investigational acellular tissue engineered vessel, or ATEV, to treat severe vascular injuries.
The long-term data from the V017 trial showed 87.1% primary and secondary patency at 12 months. No infections, amputations, or deaths related to the ATEV were reported, despite high-risk conditions and severe injuries, Humacyte said. One case of ATEV thrombosis occurred after six months, the company added.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
2
Translate
Report
15K Views
Comment
Sign in to post a comment